Verastem Oncology to Present at the 20th Annual B. Riley FBR Institutional Investor Conference

Credit: Business Wire- Published 6 days ago
BOSTON--(BUSINESS WIRE)--Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company), focused on developing and commercializing medicines seeking to improve the survival and quality of life of cancer patients, today announced that the Company will present at the 20th Annual B. Riley FBR Institutional Investor Conference on Thursday, May 23, 2019 at 1:30 p.m. PDT in Beverly Hills, CA. A live webcast of the presentation will be available on the investors section of the Companyโ€™s website at ww

You are here

You might like